Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
05/2003
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1147114B1 Novel aralkyl amines of spirofuropyridines useful in therapy
05/15/2003WO2003039677A2 Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309607A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309555A1 Process for making amlodipine maleate
05/14/2003EP1140189B1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
05/13/2003US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS
05/13/2003US6562867 Halogenated 2-phenyl-1,2-ethanediol monocarbamate derivatives
05/13/2003US6562336 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/13/2003CA2307048C Galenic preparation for prevention and treatment of hepatocarcinoma
05/08/2003US20030087803 Insertion drugs into cells, tissue; therapy for brain disorders, central nervous system disorders
05/08/2003US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders
05/08/2003US20030086985 Method of treating diabetes using plant argyrolobium roseum extract, and a process for the isolation of extract from the said plant
05/07/2003EP1200106B1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
05/07/2003CN1415372A Medicament compsn. for curing acute pharyngitis and its preparation method
05/07/2003CN1415371A Medicament for curing colpitis mycotica and trichomonal vaginitis and its preparation method
05/07/2003CN1415370A Medicament for curing stomach-ache
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559162 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
05/06/2003US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction
05/02/2003EP1140115B1 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
05/02/2003EP0984957B1 Novel form of s-omeprazole
05/01/2003WO2003035085A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
05/01/2003WO2003035072A1 Use of flibanserin in the treatment of sexual disorders
05/01/2003WO2003007912A3 Lyophilized formulation comprising olanzapine
05/01/2003WO2002096435A3 Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
05/01/2003WO2002043739A3 Dermatological formulations containing clindamycin and a zinc-salt
05/01/2003US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/01/2003CA2464331A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
04/2003
04/30/2003CN1413728A Traditional Chinese medicine composition for treating coronary heart disease and its preparation method
04/30/2003CN1413648A Chinese medicine composite for treating vomiting and diarrhea and its preparation method
04/24/2003WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
04/24/2003WO2003032995A1 Rosuvastatin in pre demented states
04/24/2003WO2003032950A1 Pharmaceutical formulation comprising (r) -bicalutamide
04/24/2003WO2003032810A2 Treatment and diagnosis of insulin resistant states
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases
04/24/2003CA2463597A1 Rosuvastatin in pre demented states
04/24/2003CA2462219A1 Pharmaceutical formulation comprising (r) -bicalutamide
04/24/2003CA2461818A1 Treatment and diagnosis of insulin resistant states
04/23/2003EP1303514A1 Process for preparing azacycloalkanoylaminothiazoles
04/23/2003EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
04/23/2003EP1175428B1 3-deoxy-desmycosin derivatives and process for their preparation
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/17/2003WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003WO2003030893A1 Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
04/17/2003WO2001094341A9 Quinazoline derivatives for the treatment of tumours
04/17/2003US20030073719 Chiral salt resolution
04/17/2003US20030073700 Central nervous system disorders; Parkinson's disease, Huntington's disease; psycological disorders
04/17/2003CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003CA2462272A1 Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
04/09/2003EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
04/09/2003CN1104905C Novel powder compositions
04/09/2003CN1104904C Natural tea for taking off the offect of drink and process for production thereof
04/08/2003US6544998 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
04/08/2003US6544518 Vaccines
04/03/2003WO2003026659A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/03/2003WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/03/2003US20030065038 Administering N-propargyl-1-aminoindan
04/03/2003US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/03/2003US20030064117 For oral administration, injection and topical application
04/03/2003CA2688860A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/02/2003EP1297108A2 Cell lines and cell-based assays for identification of androgen receptor modulators
04/02/2003EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis
04/02/2003EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
04/02/2003CN1407895A Pharmaceutical combination of ethinylestradiol and drospirenone for use as contraceptive
03/2003
03/27/2003WO2003024489A2 Combination of a nsaid and a pde-4 inhibitor
03/27/2003WO2003024444A1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
03/27/2003US20030060638 C7 carbamate substituted taxanes
03/27/2003US20030060400 A modified nucleoside comprising a purine or pyrimidine ring for treating viral infections
03/26/2003EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003CN1103593C Synergistic composition
03/25/2003US6537591 Aquatic animal treatment method and composition containing Pimenta extract
03/25/2003CA2379005A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/20/2003WO2003022824A1 Oxazolidinone and/or isoxazoline as antibacterial agents
03/20/2003WO2003022286A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
03/20/2003WO2003022279A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt
03/20/2003WO2003022275A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines
03/20/2003WO2003022269A1 Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/20/2003US20030055024 Administering in divided doses an effective amount of a vascular damaging agent or a pharmaceutically acceptable salt thereof for production of a vascular damaging effect in a warm-blooded animal such as a human
03/20/2003CA2459766A1 Oxazolidinone and/or isoxazoline as antibacterial agents
03/20/2003CA2458628A1 Use of substituted aminomethyl chromans in the treatment of movement disorders
03/20/2003CA2457717A1 Use of compounds in a dry powder inhaler
03/19/2003EP1292594A1 Quinazoline derivatives for the treatment of tumours
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/18/2003US6534534 Administering indazole-3-methyleneoxyalkanoic acid derivative to treat atherosclerosis
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020748A1 Anti-cancer cyclopenta[g]quinazoline compounds
03/13/2003WO2003020261A1 Pharmaceutical composition comprising lumiracoxib
03/13/2003WO2003020249A1 Plaster for the treatment of dysfunctions and disorders of nails
03/13/2003WO2002043762A3 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32